Technology | May 17, 2012

Philips Introduces Wireless Arrhythmia Monitoring Service

May 17, 2012 - Philips Healthcare announced the availability of CardioCare Wireless Arrhythmia Services, the latest addition to the company’s remote diagnostic arrhythmia and remote patient monitoring portfolio. This new service, available only in the United States, is designed to streamline the complex process of remotely monitoring cardiac patients and capture critical information sooner.

With Philips CardioCare, patients wear a one-piece monitor with an intuitive interface designed to help improve compliance. Using this device, patients’ heartbeats are transmitted wirelessly to highly qualified cardiac technicians at the Philips Clinical Evaluation Center, who can analyze them and alert cardiologists to critical patient data. This capability is an evolution beyond previous monitors, which transmitted patient data over telephone lines. As part of its portfolio of services, Philips distributes the wireless monitor made by TZ Medical. The monitor received U.S. Food and Drug Administration (FDA) marketing clearance last year.

“The CardioCare monitor uses advanced device technologies from TZ Medical Inc. including Monebo’s robust arrhythmia detection algorithms,” said John Lubisich, president, TZ Medical Inc. “Pairing this latest technology with Philips’ experience in the cardiac monitoring space helps simplify the process of remote monitoring for physicians.”

Philips’ helps cardiologists remotely monitor patients for a range of arrhythmias and gives them the ability to select the appropriate type of monitoring for each patient. For symptomatic patients, CardioCare is designed to help them link their symptoms to their activity level. For patients who do not experience symptoms, CardioCare can automatically recognize and record cardiac events. In either mode, the monitor will transmit recorded events wirelessly back to the Philips call center without patient interaction.         

“CardioComm Solutions provides a customized software solution that seamlessly integrates CardioCare into the Philips Evaluation Center,” said Etienne Grima, chief executive officer of CardioComm Solutions Inc. “This provides Philips’ technicians with complete cardiac data they can then translate into clear, actionable insights for doctors.”

“As the global leader in hospital cardiac monitoring, Philips strives to improve the lives of patients by simplifying the patient experience and enabling timely diagnoses of cardiac arrhythmias,” said Mark Szewczyk, general manager, Philips Remote Patient Monitoring. “CardioCare is a great addition to our portfolio — it allows us to combine smart innovations with our experience in cardiology to meet clinician and patient needs.”

For more information:

Related Content

Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Overlay Init